Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada.
Abed, Yacine; Fage, Clément; Lagüe, Patrick; Carbonneau, Julie; Papenburg, Jesse; Vinh, Donald C; Boivin, Guy.
Emerg Infect Dis
; 25(4): 838-840, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30882323
E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
Multi-agent hybrid particle swarm optimization (MAHPSO) for wastewater treatment network planning.
Canadian Studies on the Effectiveness of Community Treatment Orders.
Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.
In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses.
Abuse and smoking cessation in clinical practice.
Editor's Comment and Announcement.
Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
A framework for engaging stakeholders in water quality modeling and management: Application to the Qu'Appelle River Basin, Canada.
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.